Cargando…

The role of APOE in cognitive trajectories and motor decline in Parkinson’s disease

We aimed to investigate the role of the APOE genotype in cognitive and motor trajectories in Parkinson’s disease (PD). Using PD registry data, we retrospectively investigated a total of 253 patients with PD who underwent the Mini-Mental State Exam (MMSE) two or more times at least 5 years apart, wer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jo, Sungyang, Kim, Seon-Ok, Park, Kye Won, Lee, Seung Hyun, Hwang, Yun Su, Chung, Sun Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035327/ https://www.ncbi.nlm.nih.gov/pubmed/33837234 http://dx.doi.org/10.1038/s41598-021-86483-w

Ejemplares similares

The Effect of Blood Lipids, Type 2 Diabetes, and Body Mass Index on Parkinson’s Disease: A Korean Mendelian Randomization Study
por: Park, Kye Won, et al.
Publicado: (2023)

Association of Depression With Early Occurrence of Postural Instability in Parkinson’s Disease
por: Hwang, Yun Su, et al.
Publicado: (2023)

Microarray Genotyping Identifies New Loci Associated with Dementia in Parkinson’s Disease
por: Jo, Sungyang, et al.
Publicado: (2021)

Therapeutic Effect of Levodopa/Carbidopa/Entacapone on Sleep Disturbance in Patients with Parkinson’s Disease
por: Park, Kye Won, et al.
Publicado: (2020)

Clinical implication of stimulation-induced dyskinaesia in globus pallidus deep brain stimulation for advanced Parkinson’s disease
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Genomic Association Study for Cognitive Impairment in Parkinson's Disease
por: Park, Kye Won, et al.
Publicado: (2021)

Syringomyelia Manifesting With Pseudodystonia: A Case Report
por: Hwang, Yun Su, et al.
Publicado: (2022)

Pseudodystonia and Neuropathic Tremor in a Patient With Monomelic Amyotrophy
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Genomic Analysis Identifies New Loci Associated With Motor Complications in Parkinson's Disease
por: Ryu, Ho-Sung, et al.
Publicado: (2020)

Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease
por: Jo, Sungyang, et al.
Publicado: (2022)

Predicting cognitive decline in Parkinson’s disease using FDG-PET–based supervised learning
por: Booth, Samuel, et al.
Publicado: (2022)

Whole-genome sequencing reveals an association between small genomic deletions and an increased risk of developing Parkinson’s disease
por: Oh, Ji-Hye, et al.
Publicado: (2023)

Effect of APOE and CD33 on Cognitive Decline
por: Hayden, Kathleen M., et al.
Publicado: (2015)

Neurophysiological brain-fingerprints of motor and cognitive decline in Parkinson’s disease
por: da Silva Castanheira, Jason, et al.
Publicado: (2023)

GBA and APOE Impact Cognitive Decline in Parkinson’s Disease: A 10-Year Population-Based Study
por: Szwedo, Aleksandra A., et al.
Publicado: (2022)

A Case of Phenytoin-induced Rhabdomyolysis in Status Epilepticus
por: Kim, Hyunjin, et al.
Publicado: (2016)

Cognitive decline tracks motor progression and not disease duration in Parkinson patients
por: Riggeal, BD, et al.
Publicado: (2007)

Effect of plasma lipids and APOE genotype on cognitive decline
por: Yasuno, Fumihiko, et al.
Publicado: (2013)

Correction: Effect of APOE and CD33 on Cognitive Decline
por: Hayden, Kathleen M., et al.
Publicado: (2015)

Lower Circulating Lymphocyte Count Predicts ApoE ε4‐Related Cognitive Decline in Parkinson's Disease
por: Tsukita, Kazuto, et al.
Publicado: (2021)

Association of GBA genotype with motor and cognitive decline in Chinese Parkinson’s disease patients
por: Ren, Jingru, et al.
Publicado: (2023)

The Trajectory of Motor Deterioration to Death in Parkinson's Disease
por: Poonja, Sabrina, et al.
Publicado: (2021)

Clinical factors and dopamine transporter availability for the prediction of outcomes after globus pallidus deep brain stimulation in Parkinson’s disease
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study
por: Hong, Yun Jeong, et al.
Publicado: (2023)

Leisure Activities, APOE ε4, and Cognitive Decline: A Longitudinal Cohort Study
por: Zhang, Yun, et al.
Publicado: (2021)

Association of APOE Genotype With Heterogeneity of Cognitive Decline Rate in Alzheimer Disease
por: Qian, Jing, et al.
Publicado: (2021)

Trajectories of depressive symptoms and associated patterns of cognitive decline
por: Formánek, Tomáš, et al.
Publicado: (2020)

Depression and APOEε4 Status in Individuals with Subjective Cognitive Decline: A Meta-Analysis
por: Huang, Yue-ping, et al.
Publicado: (2020)

The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease
por: Yoo, Han Soo, et al.
Publicado: (2019)

Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia
por: Liew, Tau Ming
Publicado: (2020)

Progression of Cognitive Decline in Parkinson’s Disease
por: Roheger, Mandy, et al.
Publicado: (2018)

Subjective cognitive decline, APOE ε4, and incident mild cognitive impairment in men and women
por: Müller-Gerards, Diana, et al.
Publicado: (2019)

APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
por: Montagne, Axel, et al.
Publicado: (2020)

Race, APOE genotypes, and cognitive decline among middle-aged urban adults
por: Beydoun, May A., et al.
Publicado: (2021)

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline
por: Hochstetler, Helen, et al.
Publicado: (2015)

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD
por: Cacciamani, Federica, et al.
Publicado: (2020)

Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease
por: Giorgio, Joseph, et al.
Publicado: (2020)

Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia
por: Farnsworth von Cederwald, Bryn, et al.
Publicado: (2022)

Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline
por: den Hoedt, Sandra, et al.
Publicado: (2023)

Neurofilament light as a biomarker for motor decline in Parkinson’s disease
por: Liu, Yumei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u7kdah36k1dhcr0rq4lcr4blao